139 related articles for article (PubMed ID: 36921443)
1. Investigation of the mechanism of action of mefloquine and derivatives against the parasite Echinococcus multilocularis.
Memedovski R; Preza M; Müller J; Kämpfer T; Rufener R; de Souza MVN; da Silva ET; de Andrade GF; Braga S; Uldry AC; Buchs N; Heller M; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():114-124. PubMed ID: 36921443
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
3. Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.
Küster T; Stadelmann B; Rufener R; Risch C; Müller J; Hemphill A
Int J Antimicrob Agents; 2015 Nov; 46(5):546-51. PubMed ID: 26395219
[TBL] [Abstract][Full Text] [Related]
4. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Rufener R; Ritler D; Zielinski J; Dick L; da Silva ET; da Silva Araujo A; Joekel DE; Czock D; Goepfert C; Moraes AM; de Souza MVN; Müller J; Mevissen M; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):331-340. PubMed ID: 29933218
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
6. The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Lundström-Stadelmann B; Rufener R; Ritler D; Zurbriggen R; Hemphill A
Food Waterborne Parasitol; 2019 Jun; 15():e00040. PubMed ID: 32095613
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes.
Stadelmann B; Küster T; Scholl S; Barna F; Kropf C; Keiser J; Boykin DW; Stephens CE; Hemphill A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4866-72. PubMed ID: 21768518
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
10. In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes.
Stettler M; Fink R; Walker M; Gottstein B; Geary TG; Rossignol JF; Hemphill A
Antimicrob Agents Chemother; 2003 Feb; 47(2):467-74. PubMed ID: 12543645
[TBL] [Abstract][Full Text] [Related]
11. Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
Stadelmann B; Rufener R; Aeschbacher D; Spiliotis M; Gottstein B; Hemphill A
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004535. PubMed ID: 26967740
[TBL] [Abstract][Full Text] [Related]
12. Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.
Koike A; Becker F; Sennhenn P; Kim J; Zhang J; Hannus S; Brehm K
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010483. PubMed ID: 36190997
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of Echinococcus multilocularis miRNAs throughout metacestode development in vitro.
Macchiaroli N; Preza M; Pérez MG; Kamenetzky L; Cucher M; Koziol U; Castillo E; Berriman M; Brehm K; Rosenzvit MC
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009297. PubMed ID: 33750964
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro efficacies of mebendazole, mefloquine and nitazoxanide against cyst echinococcosis.
Liu C; Zhang H; Yin J; Hu W
Parasitol Res; 2015 Jun; 114(6):2213-22. PubMed ID: 25773183
[TBL] [Abstract][Full Text] [Related]
16. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
17. Anti-echinococcal effect of verapamil involving the regulation of the calcium/calmodulin-dependent protein kinase II response in vitro and in a murine infection model.
Gao HJ; Sun XD; Luo YP; Pang HS; Ma XM; Zhang T; Jing T; Hu W; Shen YJ; Cao JP
Parasit Vectors; 2021 Feb; 14(1):108. PubMed ID: 33588933
[TBL] [Abstract][Full Text] [Related]
18. Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
Hemphill A; Spicher M; Stadelmann B; Mueller J; Naguleswaran A; Gottstein B; Walker M
Parasitology; 2007 Nov; 134(Pt 12):1657-70. PubMed ID: 17631693
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
